Conjugon.com/home.htm Home About us Technologies News & Events Careers Contact Home Welcome to ConjuGon, Inc Our mission is to develop fundamentally new ways to prevent and treat... were once easily and successfully treated with antibiotics however bacterial strains that were resistant to many of these antibiotics developed over time. These antibiotic... bacteria, including bacteria that are resistant to all available antibiotics, and has been carefully designed to prevent the development of resistance. ConjuGon's first product for the prevention of CAUTI is currently in human clinical trials. 2010 ConjuGon Inc. All rights reserved. ...

Technologies Home About us Technologies News & Events Careers Contact Technologies ConjuGon, Inc. is developing novel technologies that use harmless bacteria as drugs. Currently... into the bladder which then protects the patient from infection with pathogenic, harmful bacteria. Bacterial interference has been used in hundreds of patients to prevent the development CAUTI..., and is exceptionally easy to administer to patients. An FDA-approved Phase Ib clinincal trial of C-1205, in patients that are highly susceptible to developing CAUTI, is in progress...

Conjugon.com/about_us.htm Home About us Technologies News & Events Careers Contact About Us ConjuGon, Inc. is focused on developing fundamentally new products to eliminate... bacterial infections. ConjuGon was founded in 2001, to develop and commercialize a novel, conjugation-based antibacterial technology discovered at the University of Wisconsin-Madison. The.... Presently, ConjuGon performs most of its Research and Development operations at its corporate headquarters in Madison, WI and contracts with leading pharmaceutical, manufacturing...